MARKET

IOVA

IOVA

Iovance Biotherp
NASDAQ
3.575
-0.085
-2.32%
Opening 13:44 05/14 EDT
OPEN
3.670
PREV CLOSE
3.660
HIGH
3.740
LOW
3.480
VOLUME
7.83M
TURNOVER
--
52 WEEK HIGH
5.63
52 WEEK LOW
1.639
MARKET CAP
1.60B
P/E (TTM)
-3.7640
1D
5D
1M
3M
1Y
5Y
1D
FDA's Makary On Brink: Why Biotech And Pharma Investors Shouldn't Panic (Or Celebrate)
Seeking Alpha · 3d ago
Weekly Report: what happened at IOVA last week (0504-0508)?
Weekly Report · 3d ago
Iovance Biotherapeutics Signals Strong Momentum in Call
TipRanks · 5d ago
Iovance Therapeutics: Q1 Earnings Miss May Have Created A Buying Opportunity
Seeking Alpha · 6d ago
Barclays Sticks to Its Buy Rating for Iovance Biotherapeutics (IOVA)
TipRanks · 6d ago
Iovance Biotherapeutics Is Maintained at Buy by Chardan Capital
Dow Jones · 6d ago
Iovance Biotherapeutics Price Target Cut to $14.00/Share From $16.00 by Chardan Capital
Dow Jones · 6d ago
Chardan Capital Maintains Buy on Iovance Biotherapeutics, Lowers Price Target to $14
Benzinga · 6d ago
More
About IOVA
Iovance Biotherapeutics, Inc. is a commercial biotechnology company. The Company is focused on developing and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. Its products include Amtagvi and Proleukin. Amtagvi is indicated for the treatment of adult patients with melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor, with or without a MEK inhibitor. It is marketing Proleukin (aldesleukin), an interleukin-2 (IL-2) product used in the Amtagvi treatment regimen and in other applications. Amtagvi and Proleukin are part of a treatment regimen that includes lymphodepletion. Its development pipeline includes multicenter trials of TIL cell therapies in additional treatment settings and indications for solid tumor cancers. Its TIL therapy includes melanoma, non-small cell lung cancer and gynecologic cancer.

Webull offers Iovance Biotherapeutics Inc stock information, including NASDAQ: IOVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IOVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IOVA stock methods without spending real money on the virtual paper trading platform.